Header Logo

Connection

Charles Feldman to Drug Resistance, Bacterial

This is a "connection" page, showing publications Charles Feldman has written about Drug Resistance, Bacterial.
Connection Strength

1,820
  1. Antibiotic resistance of pathogens causing community-acquired pneumonia. Semin Respir Crit Care Med. 2012 Jun; 33(3):232-43.
    View in: PubMed
    Score: 0,379
  2. Antimicrobial susceptibility of pneumococcal isolates causing bacteraemic pneumococcal pneumonia: analysis using current breakpoints and fluoroquinolone pharmacodynamics. Int J Antimicrob Agents. 2010 Jul; 36(1):95-7.
    View in: PubMed
    Score: 0,325
  3. Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae. J Antimicrob Chemother. 2007 Feb; 59(2):224-9.
    View in: PubMed
    Score: 0,260
  4. Streptococcus pneumoniae respiratory tract infections. Curr Opin Infect Dis. 2001 Apr; 14(2):173-9.
    View in: PubMed
    Score: 0,174
  5. Factors associated with ceftriaxone nonsusceptibility of Streptococcus pneumoniae: analysis of South African national surveillance data, 2003 to 2010. Antimicrob Agents Chemother. 2014 Jun; 58(6):3293-305.
    View in: PubMed
    Score: 0,107
  6. Overview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease. Mediators Inflamm. 2013; 2013:490346.
    View in: PubMed
    Score: 0,105
  7. Cigarette smoking and mechanisms of susceptibility to infections of the respiratory tract and other organ systems. J Infect. 2013 Sep; 67(3):169-84.
    View in: PubMed
    Score: 0,101
  8. Emergence of OXA-48 and OXA-181 carbapenemases among Enterobacteriaceae in South Africa and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract. J Clin Microbiol. 2013 Jan; 51(1):369-72.
    View in: PubMed
    Score: 0,097
  9. New insights into pneumococcal disease. Respirology. 2009 Mar; 14(2):167-79.
    View in: PubMed
    Score: 0,075
  10. Vaccines in the fight against antimicrobial resistance - perspectives from South Africa. S Afr Med J. 2024 09 02; 114(9):e2111.
    View in: PubMed
    Score: 0,055
  11. Gender as a risk factor for both antibiotic resistance and infection with pediatric serogroups/serotypes, in HIV-infected and -uninfected adults with pneumococcal bacteremia. J Infect Dis. 2004 Jun 01; 189(11):1996-2000.
    View in: PubMed
    Score: 0,054
  12. Surveillance of resistance in bacteria causing community-acquired respiratory tract infections. Clin Microbiol Infect. 2002; 8 Suppl 2:12-42.
    View in: PubMed
    Score: 0,046
  13. Appropriate use of the carbapenems. S Afr Med J. 2004 Oct; 94(10 Pt 2):857-61.
    View in: PubMed
    Score: 0,014
  14. Guideline for the management of upper respiratory tract infections. S Afr Med J. 2004 Jun; 94(6 Pt 2):475-83.
    View in: PubMed
    Score: 0,014
  15. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis. 2003 Jul 15; 37(2):230-7.
    View in: PubMed
    Score: 0,013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.